Canagliflozin attenuates isoprenaline-induced cardiac oxidative stress by stimulating multiple antioxidant and anti-inflammatory signaling pathways
出版年份 2020 全文链接
标题
Canagliflozin attenuates isoprenaline-induced cardiac oxidative stress by stimulating multiple antioxidant and anti-inflammatory signaling pathways
作者
关键词
-
出版物
Scientific Reports
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-09-02
DOI
10.1038/s41598-020-71449-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Canagliflozin inhibits vascular smooth muscle cell proliferation and migration: Role of heme oxygenase-1
- (2020) Ghazaleh Behnammanesh et al. Redox Biology
- SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
- (2019) Chenguang Li et al. Cardiovascular Diabetology
- The CANVAS Program: implications of canagliflozin on reducing cardiovascular risk in patients with type 2 diabetes mellitus
- (2019) Salvatore Carbone et al. Cardiovascular Diabetology
- Acute canagliflozin treatment protects against in vivo myocardial ischemia–reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation
- (2019) Alex Ali Sayour et al. Journal of Translational Medicine
- Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats
- (2019) Alana Aragón-Herrera et al. BIOCHEMICAL PHARMACOLOGY
- Canagliflozin exerts anti-inflammatory effects by inhibiting intracellular glucose metabolism and promoting autophagy in immune cells
- (2018) Chenke Xu et al. BIOCHEMICAL PHARMACOLOGY
- Renal protective effect of SGLT2 inhibitor dapagliflozin alone and in combination with irbesartan in a rat model of diabetic nephropathy
- (2018) Ali F. Abdel-Wahab et al. BIOMEDICINE & PHARMACOTHERAPY
- Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes
- (2018) Daisuke Matsutani et al. Cardiovascular Diabetology
- Potential mechanisms responsible for cardioprotective effects of sodium–glucose co-transporter 2 inhibitors
- (2018) Sarayut Lahnwong et al. Cardiovascular Diabetology
- Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)
- (2018) Karin Rådholm et al. CIRCULATION
- Hyperglycaemic impairment of PAR2-mediated vasodilation: Prevention by inhibition of aortic endothelial sodium-glucose-co-Transporter-2 and minimizing oxidative stress
- (2018) Mahmoud El-Daly et al. VASCULAR PHARMACOLOGY
- Canagliflozin inhibits interleukin-1β-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms
- (2018) Sarah J. Mancini et al. Scientific Reports
- Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice
- (2018) Νarjes Nasiri-Ansari et al. Cardiovascular Diabetology
- The combination of canagliflozin and omega-3 fatty acid ameliorates insulin resistance and cardiac biomarkers via modulation of inflammatory cytokines in type 2 diabetic rats
- (2018) Mohammed Mohsen Safhi et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on cisplatin-induced nephrotoxicity in mice
- (2018) Aly M. Abdelrahman et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Protective Role of Polyphenols against Vascular Inflammation, Aging and Cardiovascular Disease
- (2018) Alexa Serino et al. Nutrients
- Antioxidant Properties and Cardioprotective Mechanism of Malaysian Propolis in Rats
- (2017) Romana Ahmed et al. Evidence-based Complementary and Alternative Medicine
- Risk of Cardiovascular Events in Patients With Diabetes Mellitus on β-BlockersNovelty and Significance
- (2017) Tetsuro Tsujimoto et al. HYPERTENSION
- Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes
- (2017) James L. Januzzi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Role of β-Adrenergic Overstimulation in the Early Stages of Renal Injury
- (2017) Mariana Charleaux de Ponte et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Cardamom powder supplementation prevents obesity, improves glucose intolerance, inflammation and oxidative stress in liver of high carbohydrate high fat diet induced obese rats
- (2017) Md Mizanur Rahman et al. Lipids in Health and Disease
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Coenzyme Q10 prevents oxidative stress and fibrosis in isoprenaline induced cardiac remodeling in aged rats
- (2017) Anayt Ulla et al. BMC Pharmacology & Toxicology
- The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
- (2017) Sebastian Steven et al. Redox Biology
- The Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels
- (2016) Simon A. Hawley et al. DIABETES
- The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE −/− mice fed a western diet
- (2016) Ji Hye Han et al. DIABETOLOGIA
- The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE−/−Mice
- (2016) Weiling Leng et al. MEDIATORS OF INFLAMMATION
- Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus
- (2015) Norm Rosenthal et al. Annals of the New York Academy of Sciences
- Nicorandil enhances the efficacy of mesenchymal stem cell therapy in isoproterenol-induced heart failure in rats
- (2015) Sarah S. Mohamed et al. BIOCHEMICAL PHARMACOLOGY
- SGLT2 inhibitors: their potential reduction in blood pressure
- (2015) George Maliha et al. Journal of the American Society of Hypertension
- Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis
- (2015) Rui-Ming Liu et al. Redox Biology
- Blood pressure effects of sodium–glucose co-transport 2 (SGLT2) inhibitors
- (2014) Raymond V. Oliva et al. Journal of the American Society of Hypertension
- Isoproterenol Induces Vascular Oxidative Stress and Endothelial Dysfunction via a Giα-Coupled β2-Adrenoceptor Signaling Pathway
- (2014) Ana P. Davel et al. PLoS One
- Heme Oxygenase-1, Oxidation, Inflammation, and Atherosclerosis
- (2012) Jesus A. Araujo et al. Frontiers in Pharmacology
- Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway
- (2010) Ljubica Vucicevic et al. Autophagy
- Genistein activates endothelial nitric oxide synthase in broiler pulmonary arterial endothelial cells by an Akt-dependent mechanism
- (2010) Ying Yang et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members
- (2010) Jian Chen et al. Diabetes Therapy
- Effects of isoproterenol treatment for 7 days on inflammatory mediators in the rat aorta
- (2008) Ana Paula C. Davel et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Protective effect of (−)-epigallocatechin-gallate (EGCG) on lipid peroxide metabolism in isoproterenol induced myocardial infarction in male Wistar rats: A histopathological study
- (2007) P.T. Devika et al. BIOMEDICINE & PHARMACOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started